UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY16 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus estimate of $8.01. The company issued revenue guidance of exceed $184 billion, compared to the consensus revenue estimate of $184.24 billion.UnitedHealth Group also updated its FY17 guidance to $9.30-9.60 EPS.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% during midday trading on Monday, hitting $152.11. 5,022,344 shares of the stock traded hands. The firm has a market capitalization of $144.61 billion, a PE ratio of 25.31 and a beta of 0.63. The company’s 50-day moving average is $143.37 and its 200 day moving average is $139.61. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping the consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The business had revenue of $46.30 billion for the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the previous year, the firm posted $1.77 earnings per share. UnitedHealth Group’s quarterly revenue was up 11.6% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Inc. will post $8.01 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be paid a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s payout ratio is currently 36.93%.
Several equities research analysts recently commented on the stock. Leerink Swann reissued a buy rating on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Mizuho lowered shares of UnitedHealth Group from a buy rating to a neutral rating in a research note on Wednesday, November 9th. Credit Suisse Group AG reissued an outperform rating and set a $160.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a research note on Friday, October 21st. Vetr lowered shares of UnitedHealth Group from a buy rating to a hold rating and set a $144.66 price objective on the stock. in a research note on Tuesday, October 18th. Finally, Jefferies Group reissued a buy rating and set a $163.00 price objective on shares of UnitedHealth Group in a research note on Sunday, October 16th. Two analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of Buy and a consensus price target of $158.03.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,365 shares of the stock in a transaction on Friday, October 21st. The shares were sold at an average price of $144.18, for a total transaction of $2,071,145.70. Following the completion of the transaction, the executive vice president now owns 66,635 shares in the company, valued at $9,607,434.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The disclosure for this sale can be found here. Corporate insiders own 1.65% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. Van Hulzen Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $104,000. Eubel Brady & Suttman Asset Management Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $209,000. Bellwether Investment Group LLC purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $220,000. Ancora Advisors LLC purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $238,000. Finally, MCF Advisors LLC increased its stake in shares of UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock valued at $243,000 after buying an additional 763 shares in the last quarter. Institutional investors and hedge funds own 84.92% of the company’s stock.
About UnitedHealth Group